Terril Brothers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$283K Hold
1,082
– – 0.07% 67
2026
Q2
$272K Hold
1,082
– – 0.07% 59
2026
Q1
$235K Buy
1,082
+102
+10% +$22.6K 0.06% 70
2025
Q4
$224K Hold
980
– – 0.06% 68
2025
Q3
$227K Buy
+980
New +$200K 0.07% 72
2025
Q1
– Sell
-1,148
Closed -$204K – 59
2024
Q4
$204K Buy
1,148
+3
+0.3% +$552 0.06% 68
2024
Q3
$226K Buy
+1,145
New +$214K 0.07% 53

Other funds holding ABBV

Terril Brothers's ABBV Position: Q3 2026 in Review

Terril Brothers held its AbbVie (ABBV) position steady in Q3 2026 at 1,082 shares worth $283K. The position accounts for 0.07% of the portfolio, ranked #67.

Terril Brothers first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Terril Brothers held 1,082 shares of AbbVie worth $283K as of Q3 2026.
  • Terril Brothers left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.07% of Terril Brothers's portfolio in Q3 2026, its #67 holding.
  • Terril Brothers first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Terril Brothers's 13F filing for Q3 2026, filed 6 Nov 2026.